Business Wire
-
What Would You Do With a $10K Genome?
10/27/2008
As part of its commitment to promote basic research in the life sciences, Applied Biosystems Inc. (NYSE:ABI) today announced the creation of a grant program for genomic, epigenomic and transcriptome studies.
-
BIO-Europe 2008 To Get Biotech Industry Partnerships Started In Challenging Economic Environment
10/27/2008
In order to seek out new partnering opportunities, the top 20 big pharma companies will be in attendance on November 17-19 in Mannheim/Heidelberg, Germany for BIO-Europe 2008, the world's largest stand-alone partnering conference.
-
Guide To Successful Pharmabiotech Alliance Strategies: Providing A Comprehensive Analysis Of Driving Synergies, Avoiding Failure And Managing Relationships
10/24/2008
Research and Markets http://www.researchandmarkets.com/research/3f2fff/successful_pharmab) has announced the addition of the "Successful Pharmabiotech Alliance Strategies: Driving Synergies, Avoiding Failure and Managing Relationships" report to their offering.
-
Lupus Foundation Of America Awards More Than $1.1M In New Research Grants
10/23/2008
The Lupus Foundation of America (LFA) has awarded more than $1.1 million in new research grants and fellowships as part of its ongoing commitment to bringing down the barriers in developing new treatments and finding a cure for lupus.
-
Dalton Pharma Services And Myelin Repair Foundation Enter Into Chemistry Collaboration
10/22/2008
The Myelin Repair Foundation and Dalton Pharma Services jointly announce a chemistry collaboration to develop new potential therapeutic compounds for myelin degradation disease states such as Multiple Sclerosis.
-
Major Government Clinical Study Approved For Anadis’ AIDS Therapy
10/21/2008
Anadis Ltd. announced today that it has been informed by the Australian National Center in HIV Epidemiology and Clinical Research and the University of New South Wales
-
Future Drug Pipelines And Prospects Revealed For RNAi Therapeutics
10/20/2008
Research and Markets has announced the addition of the "The Future of RNAi Therapeutics: Drug Pipelines and Prospects" report to their offering.
-
Despite Tight Financial Market, Company With Anti-Cancer Drug In Clinical Trial Raises $3.6M In Private Placement
10/20/2008
During a time of tight credit, record-breaking stock market plunges, and shell-shocked investors, anti-cancer drug development firm Phoenix Biotechnology, Inc., has just completed a private placement in which the company raised $3.6 million from individual investors.
-
Microfluidics Introduces New Services Designed To Enhance Customer Success
10/13/2008
Microfluidics, announces the availability of several new services designed to enhance customer success and assist in customer innovation.
-
CORRECTING And REPLACING Medidata Solutions Announces New Capabilities To Streamline Clinical Trial Start-Up And FDA Submissions
10/8/2008
Second graph, second sentence of release should read: ...SDTM-compliant reports (sted: ...STDM-compliant reports).
This website uses cookies to ensure you get the best experience on our website. Learn more